title: Evaluation of potential liver donors: limits imposed by donor variables in liver transplantation.
abstract: The aim of this study was to evaluate the predictive value of different donor and recipient parameters that have been recognised previously as proven and to suggest prognostic factors for immediate liver function and final outcome after liver transplantation. We evaluated a total of 228 liver grafts transplanted in the last 3 years in our institution. Parameters were recorded for the donor (age, polytransfusion, atherosclerosis, presence of infection, episodes of hypoxia or hypotension, use of vasoactive drugs, intensive care unit stay, steatosis, and ischemia time) and recipient (red blood cell requirements, immediate liver function [score], incidence of hepatic artery thrombosis, survival, and cause of death or retransplantation). Liver biopsy after reperfusion of the donor liver was performed before closure of the abdomen. Donor age over 65 years and presence of steatosis were associated significantly with initial poor function. The mortality rate at 6 months was related to donor age over 65 years. When donor age over 65 years was combined with transfusion requirement of > 10 U of red blood cells (RBC), the incidence of graft loss increased to 53%. The probability of graft survival at two years decreased when donor age was over 65 years. Moreover, when donor age over 65 years was combined with requirement of > 10 units RBC the probability of 2-year survival was significantly reduced. This study shows, for the first time, that the use of donor livers from older donors in liver transplant procedures, requiring more than 10 U of RBC, results in a significantly worse prognosis in terms of immediate liver function and long-term survival.
authors.affiliation: Liver Transplantation Unit, Hospital Clinic i Provincial de Barcelona, Spain.
authors.forename: Ramón
authors.initials: R
authors.lastname: Rull
authors.forename: Oscar
authors.initials: O
authors.lastname: Vidal
authors.forename: Dulce
authors.initials: D
authors.lastname: Momblan
authors.forename: Francisco Xavier
authors.initials: FX
authors.lastname: González
authors.forename: Miguel Angel
authors.initials: MA
authors.lastname: López-Boado
authors.forename: Jose
authors.initials: J
authors.lastname: Fuster
authors.forename: Luis
authors.initials: L
authors.lastname: Grande
authors.forename: Miguel
authors.initials: M
authors.lastname: Bruguera
authors.forename: Katiana
authors.initials: K
authors.lastname: Cabrer
authors.forename: Juan Carlos
authors.initials: JC
authors.lastname: García-Valdecasas
mesh_terms: D000368:Aged; D000375:Aging; D017707:Erythrocyte Transfusion; D005234:Fatty Liver / Q000503:physiopathology; D006085:Graft Survival; D006801:Humans; D008099:Liver / Q000503:physiopathology; D016031:Liver Transplantation / Q000401:mortality; D008875:Middle Aged; D009926:Organ Preservation; D011336:Probability; D013997:Time Factors; D014019:Tissue Donors